Has Hammad Zafar, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $13,271 in general payments to Hammad Zafar, DPM across 245 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hammad Zafar, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hammad Zafar, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hammad Zafar, DPM

Foot & Ankle Surgery · Phoenix, AZNPI 1164809711

Payments from drug & device makers

$13,271in general payments, 2019–2025

Across 245 payments — averaging $54.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$5K
Stryker$3K
Paragon 28, Inc.$980
AbbVie$898
Paratek Pharmaceuticals, Inc.$247
Organogenesis Inc.$224
plus $3K from 45 others

What the payments were for

Travel & lodging$2,71220%
Food & beverage$6,16646%
Education$4,39433%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	16	$5,468
Stryker(2 entities)	40	$2,905
Paragon 28, Inc.	2	$980
AbbVie	45	$898
Paratek Pharmaceuticals, Inc.	24	$247
Organogenesis Inc.	6	$224
Integra Lifesciences Corporation	9	$209
Abbott	4	$176
DJO, LLC	6	$145
Bristol Myers Squibb	5	$125
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$125
Advanced Oxygen Therapy Inc.	9	$122
Amgen(2 entities)	7	$116
Smith+Nephew	5	$111
Orthofix Medical, Inc.	9	$93
Johnson & Johnson	3	$90
Medtronic	3	$79
Arteriocyte Medical Systems, Inc.	2	$77
Mimedx Group, Inc.	3	$77
KCI USA, Inc.	4	$76
Fusion Orthopedics USA, LLC	3	$75
Musculoskeletal Transplant Foundation Inc.	3	$58
Osteomed LLC	2	$57
Bard Peripheral Vascular, Inc.	1	$47
Bioventus LLC	2	$46
Alfasigma USA, Inc.	2	$46
Acell, Inc.	2	$44
Treace Medical Concepts, Inc.	2	$39
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$38
Xtant Medical Inc	1	$37
Aap Implants Inc	1	$32
Convatec Inc.	1	$31
Osteocentric Technologies, Inc.	2	$30
Kerecis Limited	1	$29
Triad Life Sciences Inc.	1	$28
Daiichi Sankyo Inc.	1	$26
Globus Medical	1	$22
Solventum Corporation	1	$22
Reprise Biomedical, Inc.	1	$21
Zimmer Biomet	1	$21
Biowound Solutions, Inc.	1	$20
Misonix Inc	1	$20
Innovation Technologies Inc	1	$20
Orpyx Medical Technologies US Inc.	1	$19
Hartmann USA, Inc.	1	$18
Lifenet Health	1	$18
Electronic Waveform Lab, Inc.	1	$16
Nevro Corp.	1	$15
Baudax Bio Inc.	1	$12
Stimwave Technologies Incorporated	1	$12
Flower Orthopedics Coporation	1	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,271 in reported general payments places this provider in the 80th percentile of 291 foot & ankle surgery providers in Arizona.

See all foot & ankle surgery providers in Arizona →

Medicare billing

Part B allowed, 2024

$259,299

Medicare patients

174

Services billed

1,567

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	46	$537
Doxycycline Hyclate	12	$180
SsdSilver Sulfadiazine	14	$165
Silver Sulfadiazine	11	$121

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Phoenix

Ryan ScottPhoenix$1.1M
Jaminelli BanksPhoenix$974K
Jeffrey HolmesPhoenix$573K
Melissa GalliPhoenix$331K
Zachary FlynnPhoenix$239K
David JaffePhoenix$111K
Kyle VaughnPhoenix$110K
Jason KaycePhoenix$57K
Devin BlandPhoenix$49K
Braden BoyerPhoenix$32K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →